MedTrace Logo

Myopia Control Effect of DIMS Spectacle Lenses in Czech Children and Young Adults

NCT05943912 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-04-02

No results posted yet for this study

Summary

The aim of this clinical study is to compare the efficacy of DIMS technology spectacle lenses with conventional single vision spectacle lenses at slowing the progression of myopia in the category of children and young adults during three years.

Conditions

  • Myopia

Interventions

OTHER

Single Vision Spectacle Lens

36 months of therapy

OTHER

Defocus Incorporated Multiple Segments (DIMS) Spectacle Lens

36 months of therapy

Sponsors & Collaborators

  • Czech Technical University in Prague

    lead OTHER

Principal Investigators

  • Marketa Zakova, Ph.D. · Czech Technical University in Prague

Eligibility

Min Age
6 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-17
Primary Completion
2026-10-10
Completion
2026-12-12

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05943912 on ClinicalTrials.gov